Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML.

Malani, D; Murumägi, A; Yadav, B; Kontro, M; Eldfors, S; Kumar, A; Karjalainen, R; Majumder, M M; Ojamies, P; Pemovska, T; Wennerberg, K; Heckman, C; Porkka, K; Wolf, M; Aittokallio, T; Kallioniemi, O

Malani, D; Murumägi, A; Yadav, B; Kontro, M; Eldfors, S; Kumar, A; Karjalainen, R; Majumder, M M; Ojamies, P; Pemovska, T; Wennerberg, K; Heckman, C; Porkka, K; Wolf, M; Aittokallio, T; Kallioniemi, O.

Affiliation

Malani D; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Murumägi A; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Yadav B; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Kontro M; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Eldfors S; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Kumar A; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Karjalainen R; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Majumder MM; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Ojamies P; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Pemovska T; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Wennerberg K; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Heckman C; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Porkka K; Hematology Research Unit Helsinki, Department of Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
Wolf M; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Aittokallio T; Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.
Kallioniemi O; Department of Mathematics and Statistics, University of Turku, Turku, Finland.

Leukemia ; 31(5): 1187-1195, 2017 05.

Article de En | MEDLINE | ID: mdl-27833094

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie aigüe myéloïde / Résistance aux médicaments antinéoplasiques / Cytarabine / Glucocorticoïdes Type d'étude: Diagnostic_studies Limites: Adult / Humans Langue: En Journal: Leukemia Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2017 Type de document: Article Pays d'affiliation: Finlande Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google